Tumor-targeting monoclonal antibodies to fzd10 and uses thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/30 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2655289

The present invention relates to an antibody or a fragment thereof which is capable of binding to a Frizzled homologue 10 (FZD10) protein, such as a mouse monoclonal antibody, a chimeric antibody and a humanized antibody. Also, the present invention relates to a method for treating and/or preventing FZD10-associated disease; a method for diagnosis or prognosis of FZD10-associated disease; and a method for in vivo imaging of FZD10 in a subject.

La présente invention concerne un anticorps ou un fragment de cet anticorps qui est susceptible de se lier à une protéine homologue Frizzled 10 (FZD10), tel qu'un anticorps monoclonal de souris, un anticorps chimérique et un anticorps humanisé. La présente invention concerne également un procédé destiné au traitement et/ou à la prévention d'une maladie associée à la FZD10, un procédé permettant de diagnostiquer ou de pronostiquer une maladie associée à la FZD10, et un procédé de technique d'imagerie in vivo de la FZD10 chez un sujet.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tumor-targeting monoclonal antibodies to fzd10 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor-targeting monoclonal antibodies to fzd10 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor-targeting monoclonal antibodies to fzd10 and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1828038

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.